Standout Papers

Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or afliberc... 2014 2026 2018 2022 274
  1. Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD (2014)
    Robert L. Avery, Alessandro Castellarin et al. British Journal of Ophthalmology

Immediate Impact

65 standout
Sub-graph 1 of 24

Citing Papers

Drug Approval for the Treatment of Geographic Atrophy: How We Got Here and Where We Need to Go
2024 Standout
Age-Related Macular Degeneration
2024 Standout
2 intermediate papers

Works of Stephen Couvillion being referenced

A Phase I, Single Ascending Dose Study of GEM103 (Recombinant Human Complement Factor H) in Patients with Geographic Atrophy
2022
SYSTEMIC PHARMACOKINETICS AND PHARMACODYNAMICS OF INTRAVITREAL AFLIBERCEPT, BEVACIZUMAB, AND RANIBIZUMAB
2017

Author Peers

Author Last Decade Papers Cites
Stephen Couvillion 530 409 11 113 12 610
Sal Rassam 318 229 17 100 20 645
Dominiek D. G. Despriet 537 355 9 148 17 687
Waheeda Rahman 430 309 31 33 19 588
W. Richard Green 437 208 28 90 8 566
Alison Martin 476 378 18 115 16 593
Joan S.K. Ng 428 223 53 83 20 673
Palwasha Khan 384 355 58 101 11 648
Yasutomo Tsukahara 551 443 10 115 27 691
Maria Gemenetzi 618 344 16 193 15 696
S. Biester 415 123 14 50 14 534

All Works

Loading papers...

Rankless by CCL
2026